NasdaqCM - Nasdaq Real Time Price
USD
Eledon Pharmaceuticals, Inc. (ELDN)
2.7700
+0.1650
(+6.33%)
As of 10:13:00 AM EST. Market Open.
Trade ELDN on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreInsider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| GROS DAVID-ALEXANDRE C Chief Executive Officer |
Stock Award(Grant) | Jul 31, 2026 | 168,663 |
| HILLSON JAN M.D. PH.D. Director |
Conversion of Exercise of derivative security | Jan 9, 2026 | 3,430 |
| KATKIN KEITH A Director |
Conversion of Exercise of derivative security | Jan 9, 2026 | 8,575 |
| KIRK ALLAN Director |
Conversion of Exercise of derivative security | Jan 9, 2026 | 3,430 |
| LEE JUNE YONG Director |
Conversion of Exercise of derivative security | Jan 9, 2026 | 3,430 |
| MCBRIDE JOHN S Director |
Conversion of Exercise of derivative security | Jan 9, 2026 | 3,430 |
| PERRIN STEVEN President |
Stock Award(Grant) | Jul 31, 2026 | 81,215 |
| ROBINSON JAMES A JR. Director |
Conversion of Exercise of derivative security | Jan 9, 2026 | 3,430 |
